Forsta Ap-Fonden’s Regeneron Pharmaceuticals Position
Does Forsta Ap-Fonden own Regeneron Pharmaceuticals (REGN)? Not currently — the last reported position was 21.4K shares worth $17M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$17M
Q4 2025
Shares
21.4K
% of Portfolio
+0.10%
Quarters Held
24
position exited
Position History REGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 21.4K | $17M | +0.10% |
| Q3 2025 | 21.9K | $12M | +0.07% |
| Q2 2025 | 21.1K | $11M | +0.07% |
| Q1 2025 | 20.8K | $13M | +0.10% |
| Q4 2024 | 22.1K | $16M | +0.11% |
| Q3 2024 | 24.5K | $26M | +0.20% |
| Q2 2024 | 22.3K | $23M | +0.21% |
| Q1 2024 | 22.9K | $22M | +0.19% |
| Q4 2023 | 20.0K | $18M | +0.18% |
| Q3 2023 | 20.5K | $17M | +0.19% |
| Q2 2023 | 20.3K | $15M | +0.16% |
| Q1 2023 | 20.5K | $17M | +0.20% |
| Q4 2022 | 25.2K | $18M | +0.21% |
| Q3 2022 | 27.8K | $19M | +0.23% |
| Q2 2022 | 28.2K | $17M | +0.22% |
| Q1 2022 | 28.7K | $20M | +0.23% |
| Q4 2021 | 30.9K | $20M | +0.20% |
| Q3 2021 | 29.9K | $18M | +0.21% |
| Q2 2021 | 28.1K | $16M | +0.18% |
| Q1 2021 | 25.8K | $12M | +0.17% |
| Q4 2020 | 21.2K | $10M | +0.15% |
| Q3 2020 | 20.0K | $11M | +0.23% |
| Q2 2020 | 13.6K | $8M | +0.22% |
| Q1 2020 | 9.2K | $4M | +0.16% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Forsta Ap-Fonden’s full portfolio or all institutional holders of REGN.